Intriguingly, comparing the MDM2 amplicon coverage value with that of TP53, in one case we observed a preferential amplification in MDM2 amplicons, hypothesizing a possible MDM2 amplification, both in 3D cell culture and in primary tumor specimens from the same sample. This evidence concerns the gene TP53 and neoplasm.